TENX

Tenax Therapeutics Inc

• Seeking Alpha·6d ago

  Tectonic Therapeutics: Currently In A Catalyst Vacuum

• TipRanks·05/16 14:36

  LifeSci Capital Sticks to Their Buy Rating for Tenax Therapeutics (TENX)

• PUBT·05/13 20:57

  Tenax Therapeutics CFO Thomas R. Staab II files initial beneficial ownership statement

• TipRanks·05/12 17:15

  Tenax Therapeutics: Buy Rating Reiterated with $27 Price Target Unchanged on Compelling Phase 3 Opportunity

• TipRanks·05/12 15:30

  Analysts Offer Insights on Healthcare Companies: Tenax Therapeutics (TENX) and Acurx Pharmaceuticals (ACXP)

• TipRanks·05/12 13:09

  Tenax Therapeutics reports Q1 EPS (35c), consensus (40c)

• Benzinga·05/12 11:11

  Earnings Scheduled For May 12, 2026

• Seeking Alpha·05/12 11:10

  Tenax Therapeutics GAAP EPS of -$0.35 beats by $0.05

• Reuters·05/12 11:08

  Tenax Therapeutics Q1 net loss widens on higher R&D costs

• Benzinga·05/12 11:08

  Tenax Therapeutics Q1 EPS $(0.35) Beats $(0.58) Estimate

• PUBT·05/12 11:02

  Tenax Therapeutics Q1 net loss widens to $15.7 million; R&D expense more than doubled to $11.5 million

• Dow Jones·05/12 11:00

  Press Release: Tenax Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

• TipRanks·05/10 02:10

  Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH), Tenax Therapeutics (TENX) and Compass Therapeutics (CMPX)

• PUBT·05/08 20:08

  Tenax Therapeutics awards inducement options for 657,500 shares to new hires

• Reuters·05/08 20:05

  TENAX THERAPEUTICS ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)